ArticleJACC. Case reports2026
Simultaneous Transcatheter Aortic Valve Replacement and Percutaneous Coronary Intervention Under ECMO Support.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with severe aortic stenosis (AS) often have concomitant coronary artery disease (CAD), but optimal timing of percutaneous coronary intervention (PCI) remains unclear, especially in those with very high risk. CASE SUMMARY: A 63-year-old man with severe AS (aortic valve area 0.9 cm DISCUSSION: Prophylactic veno-arterial extracorporeal membrane oxygenation provided a critical safety net, allowing valve recapture and repositioning despite heavy calcification and successful chronic total occlusion revascularization. This 1-stop strategy avoided staged procedures and cumulative cardiac stress. TAKE-HOME MESSAGE: For high-risk AS with complex CAD, a 1-stop TAVR-plus-PCI strategy under prophylactic ECMO support is feasible and potentially life-saving; careful imaging and advanced intraoperative techniques are essential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.